Joyce, K. M., Cameron, E. E., Sulymka, J., Protudjer, J., & Roos, L. E. (2020). Changes in Maternal Substance Use During the COVID-19 Pandemic [Preprint]. PsyArXiv. https://doi.org/10.31234/osf.io/htny8

Kc, A., Gurung, R., Kinney, M. V., Sunny, A. K., Moinuddin, M., Basnet, O., Paudel, P., Bhattarai, P., Subedi, K., Shrestha, M. P., Lawn, J. E., & Målqvist, M. (2020). Effect of the COVID-19 pandemic response on intrapartum care, stillbirth, and neonatal mortality outcomes in Nepal: A prospective observational study. The Lancet Global Health, 0(0). https://doi.org/10.1016/S2214-109X(20)30345-4

Cameron, E. E., Joyce, K., Delaquis, C., Reynolds, K., Protudjer, J., & Roos, L. E. (2020). Maternal Psychological Distress & Mental Health Services Use during the COVID-19 Pandemic [Preprint]. PsyArXiv. https://doi.org/10.31234/osf.io/a53zb

See also: Toxoplasmosis- AAPOS

What are the symptoms of newly acquired toxoplasmosis in an adult?

More than 80% of newly infected persons experience no symptoms, and are unlikely to be aware of the infection.

Symptoms may occur following an incubation period of one to two weeks after exposure and include:

*mild fever

*swollen glands

*malaise

*muscle and/or joint pain

*headache

*sore throat, and

*skin rash.

*Eye symptoms may include blurred vision or floaters during active disease.

The diagnosis can be confirmed by detecting antibodies to Toxoplasma in the blood. Swelling of the liver or spleen may be noted, and in rare cases the lungs, brain, liver, or heart may be involved. The condition usually resolves without treatment within a few months.